AGM/EGMApr 28, 2026, 04:14 PM
TARS to Hold 2026 Annual Meeting on June 25; Elect Directors
AI Summary
Tarsus Pharmaceuticals, Inc. announced its 2026 Annual Meeting of Stockholders will be held virtually on June 25, 2026. Stockholders will vote on the election of four Class III directors, an advisory resolution to approve named executive officer compensation, and the ratification of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2026. The Board of Directors unanimously recommends voting for all proposals.
Key Highlights
- 2026 Annual Meeting of Stockholders to be held virtually on June 25, 2026, at 9:00 a.m. PDT.
- Stockholders to elect Wendy Yarno, Andrew Goldberg, Scott Morrison, and David E.I. Pyott as Class III directors.
- Advisory vote on named executive officer compensation for fiscal year ended December 31, 2025.
- Ratification of Ernst & Young LLP as independent auditor for fiscal year ending December 31, 2026.
- Record date for voting is April 27, 2026, with 43,023,959 shares of Common Stock outstanding.
- Board of Directors unanimously recommends voting FOR all proposals.
Price Impact
More from TARS